Detecting mutations in the mycobacterium tuberculosis pyrazinamidase gene pnca to improve infection control and decrease drug resistance rates in human immunodeficiency virus coinfection

Matthew Z. Dudley, Patricia Sheen, Robert H Gilman, Eduardo Ticona, Jon S. Friedland, Daniela E. Kirwan, Luz Caviedes, Richard Rodriguez, Lilia Z. Cabrera, Jorge Coronel, Louis Grandjean, David A J Moore, Carlton A. Evans, Luz Huaroto, Víctor Chávez-Pérez, Mirko Zimic

Research output: Contribution to journalArticle

Abstract

Hospital infection control measures are crucial to tuberculosis (TB) control strategies within settings caring for human immunodeficiency virus (HIV)-positive patients, as these patients are at heightened risk of developing TB. Pyrazinamide (PZA) is a potent drug that effectively sterilizes persistent Mycobacterium tuberculosis bacilli. However, PZA resistance associated with mutations in the nicotinamidase/pyrazinamidase coding gene, pncA, is increasing. A total of 794 patient isolates obtained from four sites in Lima, Peru, underwent spoligotyping and drug resistance testing. In one of these sites, the HIV unit of Hospital Dos de Mayo (HDM), an isolation ward for HIV/TB coinfected patients opened during the study as an infection control intervention: circulating genotypes and drug resistance pre-and postintervention were compared. All other sites cared for HIV-negative outpatients: genotypes and drug resistance rates from these sites were compared with those from HDM. HDM patients showed high concordance between multidrug resistance, PZA resistance according to the Wayne method, the two most common genotypes (spoligotype international type [SIT] 42 of the Latino American-Mediterranean (LAM)-9 clade and SIT 53 of the T1 clade), and the two most common pncA mutations (G145A and A403C). These associations were absent among community isolates. The infection control intervention was associated with 58-92% reductions in TB caused by SIT 42 or SIT 53 genotypes (odds ratio [OR] = 0.420, P = 0.003); multidrug-resistant TB (OR = 0.349, P < 0.001); and PZA-resistant TB (OR = 0.076, P < 0.001). In conclusion, pncA mutation typing, with resistance testing and spoligotyping, was useful in identifying a nosocomial TB outbreak and demonstrating its resolution after implementation of infection control measures.

Original languageEnglish (US)
Pages (from-to)1239-1246
Number of pages8
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume95
Issue number6
DOIs
StatePublished - Dec 1 2016

Fingerprint

Infection Control
Coinfection
Mycobacterium tuberculosis
Drug Resistance
Pyrazinamide
Tuberculosis
HIV
Mutation
Genotype
Genes
Odds Ratio
Nicotinamidase
Multidrug-Resistant Tuberculosis
Hospital Units
Peru
Multiple Drug Resistance
Cross Infection
Hispanic Americans
Bacillus
Disease Outbreaks

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases
  • Virology

Cite this

Detecting mutations in the mycobacterium tuberculosis pyrazinamidase gene pnca to improve infection control and decrease drug resistance rates in human immunodeficiency virus coinfection. / Dudley, Matthew Z.; Sheen, Patricia; Gilman, Robert H; Ticona, Eduardo; Friedland, Jon S.; Kirwan, Daniela E.; Caviedes, Luz; Rodriguez, Richard; Cabrera, Lilia Z.; Coronel, Jorge; Grandjean, Louis; Moore, David A J; Evans, Carlton A.; Huaroto, Luz; Chávez-Pérez, Víctor; Zimic, Mirko.

In: American Journal of Tropical Medicine and Hygiene, Vol. 95, No. 6, 01.12.2016, p. 1239-1246.

Research output: Contribution to journalArticle

Dudley, MZ, Sheen, P, Gilman, RH, Ticona, E, Friedland, JS, Kirwan, DE, Caviedes, L, Rodriguez, R, Cabrera, LZ, Coronel, J, Grandjean, L, Moore, DAJ, Evans, CA, Huaroto, L, Chávez-Pérez, V & Zimic, M 2016, 'Detecting mutations in the mycobacterium tuberculosis pyrazinamidase gene pnca to improve infection control and decrease drug resistance rates in human immunodeficiency virus coinfection', American Journal of Tropical Medicine and Hygiene, vol. 95, no. 6, pp. 1239-1246. https://doi.org/10.4269/ajtmh.15-0711
Dudley, Matthew Z. ; Sheen, Patricia ; Gilman, Robert H ; Ticona, Eduardo ; Friedland, Jon S. ; Kirwan, Daniela E. ; Caviedes, Luz ; Rodriguez, Richard ; Cabrera, Lilia Z. ; Coronel, Jorge ; Grandjean, Louis ; Moore, David A J ; Evans, Carlton A. ; Huaroto, Luz ; Chávez-Pérez, Víctor ; Zimic, Mirko. / Detecting mutations in the mycobacterium tuberculosis pyrazinamidase gene pnca to improve infection control and decrease drug resistance rates in human immunodeficiency virus coinfection. In: American Journal of Tropical Medicine and Hygiene. 2016 ; Vol. 95, No. 6. pp. 1239-1246.
@article{73b800dd1fee420b96b182fa4ee70d40,
title = "Detecting mutations in the mycobacterium tuberculosis pyrazinamidase gene pnca to improve infection control and decrease drug resistance rates in human immunodeficiency virus coinfection",
abstract = "Hospital infection control measures are crucial to tuberculosis (TB) control strategies within settings caring for human immunodeficiency virus (HIV)-positive patients, as these patients are at heightened risk of developing TB. Pyrazinamide (PZA) is a potent drug that effectively sterilizes persistent Mycobacterium tuberculosis bacilli. However, PZA resistance associated with mutations in the nicotinamidase/pyrazinamidase coding gene, pncA, is increasing. A total of 794 patient isolates obtained from four sites in Lima, Peru, underwent spoligotyping and drug resistance testing. In one of these sites, the HIV unit of Hospital Dos de Mayo (HDM), an isolation ward for HIV/TB coinfected patients opened during the study as an infection control intervention: circulating genotypes and drug resistance pre-and postintervention were compared. All other sites cared for HIV-negative outpatients: genotypes and drug resistance rates from these sites were compared with those from HDM. HDM patients showed high concordance between multidrug resistance, PZA resistance according to the Wayne method, the two most common genotypes (spoligotype international type [SIT] 42 of the Latino American-Mediterranean (LAM)-9 clade and SIT 53 of the T1 clade), and the two most common pncA mutations (G145A and A403C). These associations were absent among community isolates. The infection control intervention was associated with 58-92{\%} reductions in TB caused by SIT 42 or SIT 53 genotypes (odds ratio [OR] = 0.420, P = 0.003); multidrug-resistant TB (OR = 0.349, P < 0.001); and PZA-resistant TB (OR = 0.076, P < 0.001). In conclusion, pncA mutation typing, with resistance testing and spoligotyping, was useful in identifying a nosocomial TB outbreak and demonstrating its resolution after implementation of infection control measures.",
author = "Dudley, {Matthew Z.} and Patricia Sheen and Gilman, {Robert H} and Eduardo Ticona and Friedland, {Jon S.} and Kirwan, {Daniela E.} and Luz Caviedes and Richard Rodriguez and Cabrera, {Lilia Z.} and Jorge Coronel and Louis Grandjean and Moore, {David A J} and Evans, {Carlton A.} and Luz Huaroto and V{\'i}ctor Ch{\'a}vez-P{\'e}rez and Mirko Zimic",
year = "2016",
month = "12",
day = "1",
doi = "10.4269/ajtmh.15-0711",
language = "English (US)",
volume = "95",
pages = "1239--1246",
journal = "American Journal of Tropical Medicine and Hygiene",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "6",

}

TY - JOUR

T1 - Detecting mutations in the mycobacterium tuberculosis pyrazinamidase gene pnca to improve infection control and decrease drug resistance rates in human immunodeficiency virus coinfection

AU - Dudley, Matthew Z.

AU - Sheen, Patricia

AU - Gilman, Robert H

AU - Ticona, Eduardo

AU - Friedland, Jon S.

AU - Kirwan, Daniela E.

AU - Caviedes, Luz

AU - Rodriguez, Richard

AU - Cabrera, Lilia Z.

AU - Coronel, Jorge

AU - Grandjean, Louis

AU - Moore, David A J

AU - Evans, Carlton A.

AU - Huaroto, Luz

AU - Chávez-Pérez, Víctor

AU - Zimic, Mirko

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Hospital infection control measures are crucial to tuberculosis (TB) control strategies within settings caring for human immunodeficiency virus (HIV)-positive patients, as these patients are at heightened risk of developing TB. Pyrazinamide (PZA) is a potent drug that effectively sterilizes persistent Mycobacterium tuberculosis bacilli. However, PZA resistance associated with mutations in the nicotinamidase/pyrazinamidase coding gene, pncA, is increasing. A total of 794 patient isolates obtained from four sites in Lima, Peru, underwent spoligotyping and drug resistance testing. In one of these sites, the HIV unit of Hospital Dos de Mayo (HDM), an isolation ward for HIV/TB coinfected patients opened during the study as an infection control intervention: circulating genotypes and drug resistance pre-and postintervention were compared. All other sites cared for HIV-negative outpatients: genotypes and drug resistance rates from these sites were compared with those from HDM. HDM patients showed high concordance between multidrug resistance, PZA resistance according to the Wayne method, the two most common genotypes (spoligotype international type [SIT] 42 of the Latino American-Mediterranean (LAM)-9 clade and SIT 53 of the T1 clade), and the two most common pncA mutations (G145A and A403C). These associations were absent among community isolates. The infection control intervention was associated with 58-92% reductions in TB caused by SIT 42 or SIT 53 genotypes (odds ratio [OR] = 0.420, P = 0.003); multidrug-resistant TB (OR = 0.349, P < 0.001); and PZA-resistant TB (OR = 0.076, P < 0.001). In conclusion, pncA mutation typing, with resistance testing and spoligotyping, was useful in identifying a nosocomial TB outbreak and demonstrating its resolution after implementation of infection control measures.

AB - Hospital infection control measures are crucial to tuberculosis (TB) control strategies within settings caring for human immunodeficiency virus (HIV)-positive patients, as these patients are at heightened risk of developing TB. Pyrazinamide (PZA) is a potent drug that effectively sterilizes persistent Mycobacterium tuberculosis bacilli. However, PZA resistance associated with mutations in the nicotinamidase/pyrazinamidase coding gene, pncA, is increasing. A total of 794 patient isolates obtained from four sites in Lima, Peru, underwent spoligotyping and drug resistance testing. In one of these sites, the HIV unit of Hospital Dos de Mayo (HDM), an isolation ward for HIV/TB coinfected patients opened during the study as an infection control intervention: circulating genotypes and drug resistance pre-and postintervention were compared. All other sites cared for HIV-negative outpatients: genotypes and drug resistance rates from these sites were compared with those from HDM. HDM patients showed high concordance between multidrug resistance, PZA resistance according to the Wayne method, the two most common genotypes (spoligotype international type [SIT] 42 of the Latino American-Mediterranean (LAM)-9 clade and SIT 53 of the T1 clade), and the two most common pncA mutations (G145A and A403C). These associations were absent among community isolates. The infection control intervention was associated with 58-92% reductions in TB caused by SIT 42 or SIT 53 genotypes (odds ratio [OR] = 0.420, P = 0.003); multidrug-resistant TB (OR = 0.349, P < 0.001); and PZA-resistant TB (OR = 0.076, P < 0.001). In conclusion, pncA mutation typing, with resistance testing and spoligotyping, was useful in identifying a nosocomial TB outbreak and demonstrating its resolution after implementation of infection control measures.

UR - http://www.scopus.com/inward/record.url?scp=85005939398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85005939398&partnerID=8YFLogxK

U2 - 10.4269/ajtmh.15-0711

DO - 10.4269/ajtmh.15-0711

M3 - Article

VL - 95

SP - 1239

EP - 1246

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

SN - 0002-9637

IS - 6

ER -